Home Site Map Email Us
Tuesday, March 19, 2019

Quiz

Title: Differentiating Among the SGLT-2 Inhibitors: Considering Cardiovascular and Other Safety Outcomes
Credits: 1.00
Differentiating Among the SGLT-2 Inhibitors: Considering Cardiovascular and Other Safety Outcomes
If you have any questions please email to: phitchman@pceconsortium.org
 
Your printable certificate will be provided as an Adobe "pdf" file. Most users typically have Adobe Reader installed. If you do not have it installed, you can download it here.
HyperLink

Question 1 of 3: Which one of the following is correct regarding canagliflozin?
-------



 
Copyright © 2004 - 2019 Primary Care Education Consortium. All rights reserved.